Avanos announces divestiture of Hyaluronic Acid product line to Channel-Markers Medical
Source: SeekingAlpha
2025-07-31 16:32:53 ET
More on Avanos Medical
- Avanos Medical Non-GAAP EPS of $0.26, revenue of $167.5M
- Seeking Alpha’s Quant Rating on Avanos Medical
- Historical earnings data for Avanos Medical
Read the full article on Seeking Alpha
For further details see:
Avanos announces divestiture of Hyaluronic Acid product line to Channel-Markers Medical
Avanos Medical Inc.
NASDAQ: AVNS
AVNS Trading
3.63% G/L:
$13.86 Last:
124,280 Volume:
$13.67 Open:
AVNS Latest News
March 02, 2026 05:28:00 pm
Avanos Medical, Inc. to Present at the 2026 Citizens Life Sciences Conference
February 26, 2026 07:00:00 am
Avanos Medical, Inc. to Nominate James Cunniff and William Burke to Board of Directors
February 24, 2026 07:00:00 am
Avanos Medical, Inc. Announces Fourth Quarter and Full-Year 2025 Results
AVNS Stock Data
$683,750,500
45,954,718
0.18%
112
N/A
Medical Equipment & Supplies
Healthcare
US
Alpharetta
